nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—CYP2C19—Methimazole—Graves' disease	0.175	0.325	CbGbCtD
Cyclosporine—CYP2C9—Methimazole—Graves' disease	0.146	0.27	CbGbCtD
Cyclosporine—CYP2D6—Methimazole—Graves' disease	0.133	0.247	CbGbCtD
Cyclosporine—CYP3A4—Methimazole—Graves' disease	0.0848	0.157	CbGbCtD
Cyclosporine—Pigmentation disorder—Methimazole—Graves' disease	0.0219	0.105	CcSEcCtD
Cyclosporine—Pigmentation disorder—Propylthiouracil—Graves' disease	0.0186	0.0895	CcSEcCtD
Cyclosporine—Traumatic liver injury—Propylthiouracil—Graves' disease	0.0167	0.0802	CcSEcCtD
Cyclosporine—FKBP1B—adipose tissue—Graves' disease	0.00918	0.0487	CbGeAlD
Cyclosporine—Interstitial lung disease—Propylthiouracil—Graves' disease	0.00879	0.0422	CcSEcCtD
Cyclosporine—FKBP4—eye—Graves' disease	0.00821	0.0435	CbGeAlD
Cyclosporine—Skin ulcer—Propylthiouracil—Graves' disease	0.00799	0.0384	CcSEcCtD
Cyclosporine—FKBP1B—thyroid gland—Graves' disease	0.00794	0.0421	CbGeAlD
Cyclosporine—FKBP4—connective tissue—Graves' disease	0.00791	0.0419	CbGeAlD
Cyclosporine—Liver injury—Propylthiouracil—Graves' disease	0.00739	0.0355	CcSEcCtD
Cyclosporine—PPIA—eye—Graves' disease	0.0068	0.0361	CbGeAlD
Cyclosporine—Lymphadenopathy—Methimazole—Graves' disease	0.00622	0.0299	CcSEcCtD
Cyclosporine—FKBP4—adipose tissue—Graves' disease	0.00607	0.0322	CbGeAlD
Cyclosporine—PPIA—Binding and entry of HIV virion—CD4—Graves' disease	0.00602	0.0939	CbGpPWpGaD
Cyclosporine—PPID—pituitary gland—Graves' disease	0.00562	0.0298	CbGeAlD
Cyclosporine—PPID—adipose tissue—Graves' disease	0.0056	0.0297	CbGeAlD
Cyclosporine—CAMLG—pituitary gland—Graves' disease	0.00554	0.0294	CbGeAlD
Cyclosporine—CAMLG—adipose tissue—Graves' disease	0.00552	0.0293	CbGeAlD
Cyclosporine—PPIF—eye—Graves' disease	0.00551	0.0292	CbGeAlD
Cyclosporine—Lymphadenopathy—Propylthiouracil—Graves' disease	0.00529	0.0254	CcSEcCtD
Cyclosporine—FKBP4—thyroid gland—Graves' disease	0.00525	0.0279	CbGeAlD
Cyclosporine—PPIB—eye—Graves' disease	0.00524	0.0278	CbGeAlD
Cyclosporine—PPP3CA—connective tissue—Graves' disease	0.00508	0.027	CbGeAlD
Cyclosporine—PPIB—connective tissue—Graves' disease	0.00505	0.0268	CbGeAlD
Cyclosporine—PPIA—pituitary gland—Graves' disease	0.00505	0.0268	CbGeAlD
Cyclosporine—PPIA—adipose tissue—Graves' disease	0.00503	0.0267	CbGeAlD
Cyclosporine—Hepatic failure—Propylthiouracil—Graves' disease	0.00502	0.0241	CcSEcCtD
Cyclosporine—PPID—thyroid gland—Graves' disease	0.00485	0.0257	CbGeAlD
Cyclosporine—CAMLG—thyroid gland—Graves' disease	0.00478	0.0253	CbGeAlD
Cyclosporine—PPIA—thyroid gland—Graves' disease	0.00435	0.0231	CbGeAlD
Cyclosporine—PPIF—pituitary gland—Graves' disease	0.00409	0.0217	CbGeAlD
Cyclosporine—PPIF—adipose tissue—Graves' disease	0.00407	0.0216	CbGeAlD
Cyclosporine—Neuropathy peripheral—Methimazole—Graves' disease	0.00401	0.0193	CcSEcCtD
Cyclosporine—Jaundice—Methimazole—Graves' disease	0.00399	0.0192	CcSEcCtD
Cyclosporine—PPP3CA—pituitary gland—Graves' disease	0.00392	0.0208	CbGeAlD
Cyclosporine—PPP3CA—adipose tissue—Graves' disease	0.0039	0.0207	CbGeAlD
Cyclosporine—PPIB—pituitary gland—Graves' disease	0.00389	0.0206	CbGeAlD
Cyclosporine—PPIB—adipose tissue—Graves' disease	0.00388	0.0206	CbGeAlD
Cyclosporine—Hepatitis—Methimazole—Graves' disease	0.00367	0.0177	CcSEcCtD
Cyclosporine—PPIF—thyroid gland—Graves' disease	0.00353	0.0187	CbGeAlD
Cyclosporine—FKBP1A—eye—Graves' disease	0.0035	0.0186	CbGeAlD
Cyclosporine—FKBP1B—Ion channel transport—GABRA3—Graves' disease	0.00345	0.0538	CbGpPWpGaD
Cyclosporine—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.00341	0.0164	CcSEcCtD
Cyclosporine—Jaundice—Propylthiouracil—Graves' disease	0.00339	0.0163	CcSEcCtD
Cyclosporine—FKBP1A—connective tissue—Graves' disease	0.00338	0.0179	CbGeAlD
Cyclosporine—PPP3CA—thyroid gland—Graves' disease	0.00338	0.0179	CbGeAlD
Cyclosporine—PPIB—thyroid gland—Graves' disease	0.00336	0.0178	CbGeAlD
Cyclosporine—Alopecia—Methimazole—Graves' disease	0.00325	0.0156	CcSEcCtD
Cyclosporine—Haemoglobin—Propylthiouracil—Graves' disease	0.00314	0.0151	CcSEcCtD
Cyclosporine—Hepatitis—Propylthiouracil—Graves' disease	0.00312	0.015	CcSEcCtD
Cyclosporine—Haemorrhage—Propylthiouracil—Graves' disease	0.00312	0.015	CcSEcCtD
Cyclosporine—Vertigo—Methimazole—Graves' disease	0.00287	0.0138	CcSEcCtD
Cyclosporine—Leukopenia—Methimazole—Graves' disease	0.00286	0.0138	CcSEcCtD
Cyclosporine—Alopecia—Propylthiouracil—Graves' disease	0.00276	0.0133	CcSEcCtD
Cyclosporine—Myalgia—Methimazole—Graves' disease	0.00272	0.0131	CcSEcCtD
Cyclosporine—Arthralgia—Methimazole—Graves' disease	0.00272	0.0131	CcSEcCtD
Cyclosporine—Dysgeusia—Propylthiouracil—Graves' disease	0.00266	0.0128	CcSEcCtD
Cyclosporine—Oedema—Methimazole—Graves' disease	0.00261	0.0125	CcSEcCtD
Cyclosporine—FKBP1A—pituitary gland—Graves' disease	0.0026	0.0138	CbGeAlD
Cyclosporine—FKBP1A—adipose tissue—Graves' disease	0.00259	0.0137	CbGeAlD
Cyclosporine—Thrombocytopenia—Methimazole—Graves' disease	0.00255	0.0123	CcSEcCtD
Cyclosporine—Vertigo—Propylthiouracil—Graves' disease	0.00244	0.0117	CcSEcCtD
Cyclosporine—Leukopenia—Propylthiouracil—Graves' disease	0.00243	0.0117	CcSEcCtD
Cyclosporine—SLC10A2—Orphan transporters—GABRA3—Graves' disease	0.0024	0.0375	CbGpPWpGaD
Cyclosporine—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00238	0.0114	CcSEcCtD
Cyclosporine—Paraesthesia—Methimazole—Graves' disease	0.00234	0.0113	CcSEcCtD
Cyclosporine—PPP3CA—T-Cell Receptor and Co-stimulatory Signaling—CTLA4—Graves' disease	0.00232	0.0362	CbGpPWpGaD
Cyclosporine—Somnolence—Methimazole—Graves' disease	0.00232	0.0111	CcSEcCtD
Cyclosporine—Arthralgia—Propylthiouracil—Graves' disease	0.00231	0.0111	CcSEcCtD
Cyclosporine—Myalgia—Propylthiouracil—Graves' disease	0.00231	0.0111	CcSEcCtD
Cyclosporine—PPP3R2—Alzheimers Disease—FAS—Graves' disease	0.00231	0.036	CbGpPWpGaD
Cyclosporine—Dyspepsia—Methimazole—Graves' disease	0.0023	0.011	CcSEcCtD
Cyclosporine—FKBP1A—thyroid gland—Graves' disease	0.00224	0.0119	CbGeAlD
Cyclosporine—Oedema—Propylthiouracil—Graves' disease	0.00222	0.0107	CcSEcCtD
Cyclosporine—PPIA—Early Phase of HIV Life Cycle—CD4—Graves' disease	0.00221	0.0345	CbGpPWpGaD
Cyclosporine—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00217	0.0104	CcSEcCtD
Cyclosporine—PPID—C-MYB transcription factor network—CD4—Graves' disease	0.00216	0.0337	CbGpPWpGaD
Cyclosporine—ABCC3—adipose tissue—Graves' disease	0.00209	0.0111	CbGeAlD
Cyclosporine—ABCC10—pituitary gland—Graves' disease	0.00208	0.0111	CbGeAlD
Cyclosporine—ABCC10—adipose tissue—Graves' disease	0.00208	0.011	CbGeAlD
Cyclosporine—Urticaria—Methimazole—Graves' disease	0.00207	0.00996	CcSEcCtD
Cyclosporine—Body temperature increased—Methimazole—Graves' disease	0.00206	0.00991	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00202	0.00971	CcSEcCtD
Cyclosporine—Paraesthesia—Propylthiouracil—Graves' disease	0.00199	0.00957	CcSEcCtD
Cyclosporine—Somnolence—Propylthiouracil—Graves' disease	0.00197	0.00948	CcSEcCtD
Cyclosporine—Dyspepsia—Propylthiouracil—Graves' disease	0.00195	0.00939	CcSEcCtD
Cyclosporine—Pruritus—Methimazole—Graves' disease	0.00185	0.00887	CcSEcCtD
Cyclosporine—ABCC3—thyroid gland—Graves' disease	0.00181	0.00957	CbGeAlD
Cyclosporine—ABCC10—thyroid gland—Graves' disease	0.0018	0.00953	CbGeAlD
Cyclosporine—PPP3CA—T-Cell Receptor and Co-stimulatory Signaling—CD8A—Graves' disease	0.00179	0.0279	CbGpPWpGaD
Cyclosporine—Urticaria—Propylthiouracil—Graves' disease	0.00176	0.00847	CcSEcCtD
Cyclosporine—Body temperature increased—Propylthiouracil—Graves' disease	0.00175	0.00843	CcSEcCtD
Cyclosporine—Vomiting—Methimazole—Graves' disease	0.00166	0.00797	CcSEcCtD
Cyclosporine—Rash—Methimazole—Graves' disease	0.00165	0.00791	CcSEcCtD
Cyclosporine—Dermatitis—Methimazole—Graves' disease	0.00164	0.0079	CcSEcCtD
Cyclosporine—Headache—Methimazole—Graves' disease	0.00163	0.00786	CcSEcCtD
Cyclosporine—Pruritus—Propylthiouracil—Graves' disease	0.00157	0.00754	CcSEcCtD
Cyclosporine—Nausea—Methimazole—Graves' disease	0.00155	0.00745	CcSEcCtD
Cyclosporine—ABCC1—pituitary gland—Graves' disease	0.00147	0.00782	CbGeAlD
Cyclosporine—ABCC1—adipose tissue—Graves' disease	0.00147	0.00778	CbGeAlD
Cyclosporine—Vomiting—Propylthiouracil—Graves' disease	0.00141	0.00678	CcSEcCtD
Cyclosporine—Rash—Propylthiouracil—Graves' disease	0.0014	0.00672	CcSEcCtD
Cyclosporine—Dermatitis—Propylthiouracil—Graves' disease	0.0014	0.00672	CcSEcCtD
Cyclosporine—Headache—Propylthiouracil—Graves' disease	0.00139	0.00668	CcSEcCtD
Cyclosporine—FKBP4—Glucocorticoid receptor regulatory network—ICAM1—Graves' disease	0.00138	0.0215	CbGpPWpGaD
Cyclosporine—PPP3R2—Alzheimers Disease—IL1B—Graves' disease	0.00135	0.0211	CbGpPWpGaD
Cyclosporine—Nausea—Propylthiouracil—Graves' disease	0.00132	0.00633	CcSEcCtD
Cyclosporine—PPP3R2—MAPK Signaling Pathway—FASLG—Graves' disease	0.00131	0.0204	CbGpPWpGaD
Cyclosporine—FKBP1A—Calcium signaling in the CD4+ TCR pathway—FASLG—Graves' disease	0.0013	0.0203	CbGpPWpGaD
Cyclosporine—ABCC1—thyroid gland—Graves' disease	0.00127	0.00674	CbGeAlD
Cyclosporine—PPP3R2—MAPK Signaling Pathway—FAS—Graves' disease	0.00126	0.0197	CbGpPWpGaD
Cyclosporine—CYP2C8—pituitary gland—Graves' disease	0.00126	0.00666	CbGeAlD
Cyclosporine—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IL2RA—Graves' disease	0.00125	0.0195	CbGpPWpGaD
Cyclosporine—ABCG2—pituitary gland—Graves' disease	0.00122	0.00647	CbGeAlD
Cyclosporine—ABCG2—adipose tissue—Graves' disease	0.00122	0.00644	CbGeAlD
Cyclosporine—FKBP1B—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.0012	0.0187	CbGpPWpGaD
Cyclosporine—CYP3A5—adipose tissue—Graves' disease	0.00113	0.00598	CbGeAlD
Cyclosporine—FKBP1B—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.00105	0.0164	CbGpPWpGaD
Cyclosporine—ABCG2—thyroid gland—Graves' disease	0.00105	0.00558	CbGeAlD
Cyclosporine—FKBP4—Glucocorticoid receptor regulatory network—IFNG—Graves' disease	0.00105	0.0163	CbGpPWpGaD
Cyclosporine—FKBP1B—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.00102	0.0158	CbGpPWpGaD
Cyclosporine—PPP3R2—Alzheimers Disease—TNF—Graves' disease	0.00098	0.0153	CbGpPWpGaD
Cyclosporine—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IFNG—Graves' disease	0.000824	0.0128	CbGpPWpGaD
Cyclosporine—PPP3R2—MAPK Signaling Pathway—IL1B—Graves' disease	0.000738	0.0115	CbGpPWpGaD
Cyclosporine—PPP3CA—Alzheimers Disease—FAS—Graves' disease	0.000726	0.0113	CbGpPWpGaD
Cyclosporine—PPP3CA—Spinal Cord Injury—CXCL10—Graves' disease	0.000685	0.0107	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000664	0.0104	CbGpPWpGaD
Cyclosporine—ABCB1—pituitary gland—Graves' disease	0.000602	0.00319	CbGeAlD
Cyclosporine—ABCB1—adipose tissue—Graves' disease	0.000599	0.00318	CbGeAlD
Cyclosporine—PPIA—Host Interactions of HIV factors—HLA-A—Graves' disease	0.000591	0.00922	CbGpPWpGaD
Cyclosporine—SLC10A2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000587	0.00915	CbGpPWpGaD
Cyclosporine—PPP3CA—Amyotrophic lateral sclerosis (ALS)—TNF—Graves' disease	0.000554	0.00864	CbGpPWpGaD
Cyclosporine—ABCC10—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000552	0.0086	CbGpPWpGaD
Cyclosporine—PPP3R2—MAPK Signaling Pathway—TNF—Graves' disease	0.000536	0.00836	CbGpPWpGaD
Cyclosporine—FKBP1A—Spinal Cord Injury—CXCL10—Graves' disease	0.000531	0.00829	CbGpPWpGaD
Cyclosporine—ABCB1—thyroid gland—Graves' disease	0.000519	0.00275	CbGeAlD
Cyclosporine—PPIB—Extracellular matrix organization—ICAM1—Graves' disease	0.000512	0.00798	CbGpPWpGaD
Cyclosporine—FKBP1A—TGF-beta Receptor Signaling—IFNG—Graves' disease	0.000501	0.00781	CbGpPWpGaD
Cyclosporine—PPP3CA—Spinal Cord Injury—ICAM1—Graves' disease	0.000454	0.00708	CbGpPWpGaD
Cyclosporine—PPP3CA—C-MYB transcription factor network—CD4—Graves' disease	0.000438	0.00683	CbGpPWpGaD
Cyclosporine—FKBP1B—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000431	0.00672	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000428	0.00667	CbGpPWpGaD
Cyclosporine—PPP3CA—Alzheimers Disease—IL1B—Graves' disease	0.000425	0.00663	CbGpPWpGaD
Cyclosporine—PPP3CA—Cardiac Hypertrophic Response—TNF—Graves' disease	0.000412	0.00643	CbGpPWpGaD
Cyclosporine—PPP3CA—MAPK Signaling Pathway—FASLG—Graves' disease	0.000412	0.00642	CbGpPWpGaD
Cyclosporine—PPP3CA—MAPK Signaling Pathway—FAS—Graves' disease	0.000397	0.00619	CbGpPWpGaD
Cyclosporine—PPIA—HIV Infection—HLA-A—Graves' disease	0.000384	0.00599	CbGpPWpGaD
Cyclosporine—PPIA—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000382	0.00595	CbGpPWpGaD
Cyclosporine—PPIA—Host Interactions of HIV factors—CD4—Graves' disease	0.000381	0.00594	CbGpPWpGaD
Cyclosporine—PPIA—HIV Life Cycle—CD4—Graves' disease	0.000359	0.00559	CbGpPWpGaD
Cyclosporine—FKBP1A—Spinal Cord Injury—ICAM1—Graves' disease	0.000352	0.00549	CbGpPWpGaD
Cyclosporine—PPP3CA—Spinal Cord Injury—IFNG—Graves' disease	0.000346	0.00539	CbGpPWpGaD
Cyclosporine—FKBP1A—TGF-beta Receptor Signaling—TNF—Graves' disease	0.000324	0.00506	CbGpPWpGaD
Cyclosporine—PPP3CA—Alzheimers Disease—TNF—Graves' disease	0.000308	0.00481	CbGpPWpGaD
Cyclosporine—PPP3CA—Spinal Cord Injury—IL1B—Graves' disease	0.000308	0.00481	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—GC—Graves' disease	0.000296	0.00461	CbGpPWpGaD
Cyclosporine—PPP3CA—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	0.000294	0.00458	CbGpPWpGaD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000288	0.0045	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—IFIH1—Graves' disease	0.00028	0.00437	CbGpPWpGaD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000278	0.00433	CbGpPWpGaD
Cyclosporine—FKBP1A—Spinal Cord Injury—IFNG—Graves' disease	0.000268	0.00418	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000252	0.00393	CbGpPWpGaD
Cyclosporine—PPIA—HIV Infection—CD4—Graves' disease	0.000248	0.00386	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000242	0.00377	CbGpPWpGaD
Cyclosporine—FKBP1A—Spinal Cord Injury—IL1B—Graves' disease	0.000239	0.00373	CbGpPWpGaD
Cyclosporine—PPIA—Disease—B3GNT2—Graves' disease	0.000233	0.00363	CbGpPWpGaD
Cyclosporine—PPP3CA—MAPK Signaling Pathway—IL1B—Graves' disease	0.000232	0.00362	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—B3GNT2—Graves' disease	0.000224	0.00349	CbGpPWpGaD
Cyclosporine—PPP3CA—Spinal Cord Injury—TNF—Graves' disease	0.000224	0.00349	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—HLA-E—Graves' disease	0.00022	0.00344	CbGpPWpGaD
Cyclosporine—ABCC3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000214	0.00333	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.00021	0.00328	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—HLA-E—Graves' disease	0.000203	0.00317	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—CD40—Graves' disease	0.000198	0.0031	CbGpPWpGaD
Cyclosporine—PPIA—Hemostasis—IL2RA—Graves' disease	0.000197	0.00307	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—CTLA4—Graves' disease	0.000196	0.00305	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—B3GNT2—Graves' disease	0.000193	0.00302	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—GC—Graves' disease	0.00019	0.00297	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—TSHR—Graves' disease	0.00019	0.00296	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000189	0.00295	CbGpPWpGaD
Cyclosporine—SLCO1A2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000186	0.0029	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.00018	0.00281	CbGpPWpGaD
Cyclosporine—SLC22A6—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000175	0.00273	CbGpPWpGaD
Cyclosporine—FKBP1A—Spinal Cord Injury—TNF—Graves' disease	0.000173	0.00271	CbGpPWpGaD
Cyclosporine—ABCC2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000169	0.00264	CbGpPWpGaD
Cyclosporine—PPP3CA—MAPK Signaling Pathway—TNF—Graves' disease	0.000169	0.00263	CbGpPWpGaD
Cyclosporine—ABCC1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000167	0.00261	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—IFIH1—Graves' disease	0.000163	0.00254	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—HLA-DQB1—Graves' disease	0.000161	0.00251	CbGpPWpGaD
Cyclosporine—SLCO1B1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000159	0.00248	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—HLA-B—Graves' disease	0.000157	0.00245	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—B3GNT2—Graves' disease	0.00015	0.00234	CbGpPWpGaD
Cyclosporine—ABCG2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000147	0.0023	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—HLA-B—Graves' disease	0.000145	0.00226	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—B3GNT2—Graves' disease	0.000144	0.00225	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—FASLG—Graves' disease	0.000141	0.00221	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—FAS—Graves' disease	0.000136	0.00213	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—IL2RA—Graves' disease	0.000136	0.00211	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—HLA-A—Graves' disease	0.000134	0.00209	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—HLA-E—Graves' disease	0.000128	0.002	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CD40—Graves' disease	0.000125	0.00196	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CTLA4—Graves' disease	0.000124	0.00193	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—CXCL10—Graves' disease	0.000123	0.00191	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—HLA-DRB1—Graves' disease	0.000122	0.00191	CbGpPWpGaD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000118	0.00184	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—GC—Graves' disease	0.000112	0.00175	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TSHR—Graves' disease	0.000112	0.00175	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—GC—Graves' disease	0.000108	0.00168	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000103	0.00161	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—HLA-DQB1—Graves' disease	0.000102	0.00159	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CD8A—Graves' disease	9.51e-05	0.00148	CbGpPWpGaD
Cyclosporine—PPIA—Disease—HLA-A—Graves' disease	9.42e-05	0.00147	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—IL2RA—Graves' disease	9.38e-05	0.00146	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—CD4—Graves' disease	9.38e-05	0.00146	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—GC—Graves' disease	9.37e-05	0.00146	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—GC—Graves' disease	9.23e-05	0.00144	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—HLA-B—Graves' disease	9.15e-05	0.00143	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—IFNG—Graves' disease	8.94e-05	0.0014	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TSHR—Graves' disease	8.7e-05	0.00136	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—IL2RA—Graves' disease	8.57e-05	0.00134	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—B3GNT2—Graves' disease	8.51e-05	0.00133	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—HLA-A—Graves' disease	8.48e-05	0.00132	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—GC—Graves' disease	8.43e-05	0.00132	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—GC—Graves' disease	8.42e-05	0.00131	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—B3GNT2—Graves' disease	8.16e-05	0.00127	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—GC—Graves' disease	8.01e-05	0.00125	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—IL1B—Graves' disease	7.98e-05	0.00124	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	7.96e-05	0.00124	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—HLA-A—Graves' disease	7.83e-05	0.00122	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—HLA-DRB1—Graves' disease	7.74e-05	0.00121	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—B3GNT2—Graves' disease	7.63e-05	0.00119	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—ICAM1—Graves' disease	7.43e-05	0.00116	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—GC—Graves' disease	7.42e-05	0.00116	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—GC—Graves' disease	7.35e-05	0.00115	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CXCL10—Graves' disease	7.25e-05	0.00113	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—B3GNT2—Graves' disease	7.1e-05	0.00111	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	6.98e-05	0.00109	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	6.73e-05	0.00105	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—B3GNT2—Graves' disease	6.39e-05	0.000997	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—B3GNT2—Graves' disease	6.07e-05	0.000947	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—HLA-A—Graves' disease	6.07e-05	0.000946	CbGpPWpGaD
Cyclosporine—PPIA—Disease—CD4—Graves' disease	6.07e-05	0.000946	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—TNF—Graves' disease	5.79e-05	0.000903	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—IFNG—Graves' disease	5.65e-05	0.000882	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—B3GNT2—Graves' disease	5.62e-05	0.000877	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CXCL10—Graves' disease	5.62e-05	0.000877	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—B3GNT2—Graves' disease	5.57e-05	0.000869	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—IL2RA—Graves' disease	5.54e-05	0.000864	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CD4—Graves' disease	5.46e-05	0.000852	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GC—Graves' disease	5.32e-05	0.000829	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—IL1B—Graves' disease	5.04e-05	0.000787	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—CD4—Graves' disease	5.04e-05	0.000786	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GC—Graves' disease	4.6e-05	0.000718	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL2RA—Graves' disease	4.3e-05	0.00067	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GC—Graves' disease	4.11e-05	0.000641	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—B3GNT2—Graves' disease	4.03e-05	0.000628	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GC—Graves' disease	4.01e-05	0.000626	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—CD4—Graves' disease	3.91e-05	0.00061	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GC—Graves' disease	3.78e-05	0.00059	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GC—Graves' disease	3.75e-05	0.000585	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—B3GNT2—Graves' disease	3.49e-05	0.000544	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—B3GNT2—Graves' disease	3.11e-05	0.000486	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—HLA-A—Graves' disease	3.09e-05	0.000482	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—B3GNT2—Graves' disease	3.04e-05	0.000474	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—B3GNT2—Graves' disease	2.87e-05	0.000447	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	2.86e-05	0.000446	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—B3GNT2—Graves' disease	2.84e-05	0.000443	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GC—Graves' disease	2.47e-05	0.000385	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CD4—Graves' disease	1.99e-05	0.00031	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—B3GNT2—Graves' disease	1.87e-05	0.000292	CbGpPWpGaD
